Skip to main content

stock

HRMY · Harmony Biosciences Holdings, Inc.

What Harmony Biosciences Holdings, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live HRMY price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on HRMY.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
58,236,393 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
75.4%
Operating
24.0%
Net
18.9%

Returns

ROE
18.1%
ROA
13.2%

Health

Current ratio
3.5x
Debt/equity
0.2x

Deep value

NCAV
$440.49M
NCAV per share
$7.56
Price/NCAV
Locked
NNWC
$262.35M
NNWC per share
$4.50
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$261.28M$198.08M$89.32M$75.43M
10-Q filed 2026-08-04
2026-03-31$215.39M$170.88M$37.29M$32.49M
10-Q filed 2026-05-07
2025-12-31$243.78M$175.23M$38.56M$22.49M
10-K filed 2026-02-24
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$239.46M$179.81M$65.49M$50.87M
10-Q filed 2025-11-04
2025-06-30$200.49M$162.34M$48.18M$39.78M
10-Q filed 2026-08-04
2025-03-31$184.73M$152.74M$56.24M$45.56M
10-Q filed 2026-05-07
2024-12-31$201.27M$146.86M$55.73M$49.48M
10-K filed 2026-02-24
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$186.04M$143.26M$61.71M$46.09M
10-Q filed 2025-11-04
Assets
$1.37B
Equity
$999.24M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$868.45M$208.47M$158.69M$347.89M
2024-12-31$714.73M$190.83M$145.49M$218.67M
2023-12-31$582.02M$192.03M$128.85M$219.07M
2022-12-31$437.86M$120.19M$181.47M$144.29M
2021-12-31$305.44M$87.53M$34.60M$98.26M
2020-12-31$159.74M$16.99M-$36.94M-$2.99M
2019-12-31$6.00M-$145.90M-$151.98M-$75.58M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

News

Stories that named HRMY, and the market events around them.

Sign in to see this

Board

The HRMY board could not be loaded.

Retry the HRMY board

nakagai

Signals on HRMY come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the HRMY board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Harmony Biosciences Holdings, Inc. (HRMY): SEC filings, financials and insider trades · Nakagai